Homology Medicines - Stock Split History | FIXX

Stock split history for Homology Medicines since 2019. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Homology Medicines Annual Stock Splits
Homology Medicines Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.943B $0.004B
Homology Medicines Inc. is a genetic medicines company. Its platform offers human hematopoietic stem cell derived adeno-associated virus vectors to treat disease-causing mutations through gene correction, insertion and knockout. Homology Medicines Inc. is based in BEDFORD MA.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $54.453B 9.93
Mylan (MYL) United Kingdom $10.983B 4.84
Teva Pharmaceutical Industries (TEVA) Israel $8.506B 3.34
Bausch Health Cos (BHC) Canada $8.160B 5.44
Dr Reddy's Laboratories (RDY) India $6.323B 21.27
ASPEN PHARMACR (APNHY) South Africa $2.946B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.505B 14.72
Amphastar Pharmaceuticals (AMPH) United States $1.002B 49.35
Voyager Therapeutics (VYGR) United States $0.669B 0.00
Akorn (AKRX) United States $0.473B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.470B 0.00
CymaBay Therapeutics (CBAY) United States $0.385B 0.00
Assembly Biosciences (ASMB) United States $0.381B 0.00
Mallinckrodt Public Limited Company (MNK) United Kingdom $0.213B 0.29
Zynerba Pharmaceuticals (ZYNE) United States $0.205B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.184B 0.00
Sol-Gel Technologies (SLGL) Israel $0.162B 0.00
Teligent (TLGT) United States $0.052B 0.00
China Pharma Holdings (CPHI) China $0.012B 0.00